Clinical Trial

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Study acronym: PRIMO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This pilot study aims to trial multimodal early response assessment to enable therapy adaptions in the context of non-operative therapy strategies of locally advanced rectal cancer (LARC) for development of a non-invasive response prediction model.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-08-30; most recent amendment 2025-08-31.
Status change: Recruiting → Active, Not Recruiting 2025-08-31
Status change: Not Yet Recruiting → Recruiting 2022-11-29
Trial Details
NCT Number NCT05524012
Lead Sponsor Jena University Hospital
Conditions Locally Advanced Rectal Carcinoma, Neoadjuvant Treatment, Radiotherapy, Adaptive Treatment
Enrollment 40 participants
Start Date 2022-11-30
Primary Completion 2026-01-31 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-06